NO892743D0 - Fremgangsmaate for fremstilling av farmakologisk aktive glycerolderivater. - Google Patents

Fremgangsmaate for fremstilling av farmakologisk aktive glycerolderivater.

Info

Publication number
NO892743D0
NO892743D0 NO892743A NO892743A NO892743D0 NO 892743 D0 NO892743 D0 NO 892743D0 NO 892743 A NO892743 A NO 892743A NO 892743 A NO892743 A NO 892743A NO 892743 D0 NO892743 D0 NO 892743D0
Authority
NO
Norway
Prior art keywords
procedure
preparation
pharmacologically active
glycerol derivatives
active glycerol
Prior art date
Application number
NO892743A
Other languages
English (en)
Other versions
NO892743L (no
NO177495C (no
NO177495B (no
Inventor
Kazuo Okano
Osamu Asano
Naoyuki Shimomura
Tetsuya Kawahara
Shinya Abe
Shuhei Miyazawa
Mitsuaki Miyamoto
Hiroyuki Yoshimura
Koukichi Harada
Junsaku Nagaoka
Tsutomu Kawata
Tsutomu Yoshimura
Hiromasa Suzuki
Shigeru Souda
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO892743D0 publication Critical patent/NO892743D0/no
Publication of NO892743L publication Critical patent/NO892743L/no
Publication of NO177495B publication Critical patent/NO177495B/no
Publication of NO177495C publication Critical patent/NO177495C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO892743A 1988-07-04 1989-07-03 Analogifremgangsmåte for fremstilling av terapeutisk aktive glyserinderivater NO177495C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16638688 1988-07-04

Publications (4)

Publication Number Publication Date
NO892743D0 true NO892743D0 (no) 1989-07-03
NO892743L NO892743L (no) 1990-01-05
NO177495B NO177495B (no) 1995-06-19
NO177495C NO177495C (no) 1995-09-27

Family

ID=15830457

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892743A NO177495C (no) 1988-07-04 1989-07-03 Analogifremgangsmåte for fremstilling av terapeutisk aktive glyserinderivater

Country Status (20)

Country Link
US (1) US5037827A (no)
EP (1) EP0353474B1 (no)
JP (1) JP2766319B2 (no)
KR (1) KR910006127B1 (no)
CN (1) CN1041920C (no)
AT (1) ATE120734T1 (no)
AU (1) AU621634B2 (no)
CA (1) CA1334753C (no)
DD (1) DD297814A5 (no)
DE (1) DE68922035T2 (no)
DK (1) DK329189A (no)
ES (1) ES2070148T3 (no)
FI (1) FI97883C (no)
GR (1) GR3015704T3 (no)
HU (2) HU208119B (no)
NO (1) NO177495C (no)
NZ (1) NZ229789A (no)
PH (1) PH26045A (no)
PT (1) PT91051B (no)
RU (1) RU2040521C1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662606A1 (fr) * 1990-06-01 1991-12-06 Rhone Poulenc Sante Compositions pharmaceutiques pour le traitement de la fibrillation ventriculaire, du syndrome de menace de l'infarctus du myocarde et de l'angine de poitrine contenant le n-(benzoyl-3 phenyl) (pyridyl-3)-3 1h,3h-pyrrolo[1,2-c]thiazolecarboxamide-7.
US5136040A (en) * 1991-02-26 1992-08-04 Eli Lilly And Company Preparation of substituted tetrahydropyridines
WO1994000447A1 (en) * 1992-06-30 1994-01-06 Pohang Iron & Steel Co., Ltd. Novel cyclic lipid derivatives as potent paf antagonists
US5700817A (en) * 1992-06-30 1997-12-23 Pohang Iron & Steel Co., Ltd. Cyclic lipid derivatives as potent PAF antagonists
JPH07285866A (ja) * 1994-02-22 1995-10-31 Eisai Co Ltd 臓器障害予防・治療・改善剤
US5854279A (en) * 1996-06-04 1998-12-29 Eisai Co., Ltd Therapeutic agent for dermatosis
US6177067B1 (en) 1996-08-09 2001-01-23 Shiseido Company, Ltd. Hair revitalizing tonic composition containing a 2,2-dimethylpropanediol compound and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965419D1 (en) * 1979-02-19 1983-07-07 Bbc Brown Boveri & Cie Exhaust-gas driven turbocharger having two stages
ZA8410014B (en) * 1983-12-30 1985-08-28 Hoffmann La Roche Glycerol derivatives
DK160818C (da) * 1983-12-30 1991-10-07 Hoffmann La Roche N-ring-holdige glycerolderivater, fremgangsmaade til fremstilling deraf, anvendelse deraf til fremstilling af et blodpladeaktiveringsfaktorhaemmende middel samt laegemidler indeholdende en saadan forbindelse
DE3586746D1 (de) * 1984-04-03 1992-11-19 Takeda Chemical Industries Ltd Lipidderivate, ihre produktion und verwendung.
US4737518A (en) * 1984-04-03 1988-04-12 Takeda Chemical Industries, Ltd. Lipid derivatives, their production and use
US4863941A (en) * 1985-06-18 1989-09-05 Hoffmann-La Roche Inc. Glycerol derivatives
JPH0815643B2 (ja) * 1988-05-19 1996-02-21 新日本製鐵株式会社 幅可変薄スラブ連続鋳造機の湯面レベル制御方法

Also Published As

Publication number Publication date
NO892743L (no) 1990-01-05
NO177495C (no) 1995-09-27
KR910006127B1 (ko) 1991-08-13
AU621634B2 (en) 1992-03-19
EP0353474A2 (en) 1990-02-07
GR3015704T3 (en) 1995-07-31
HU208119B (en) 1993-08-30
FI97883C (fi) 1997-03-10
FI893099A (fi) 1990-01-05
EP0353474B1 (en) 1995-04-05
DE68922035T2 (de) 1995-09-14
PT91051B (pt) 1995-06-30
CN1041920C (zh) 1999-02-03
CN1039414A (zh) 1990-02-07
PT91051A (pt) 1990-02-08
DE68922035D1 (de) 1995-05-11
ES2070148T3 (es) 1995-06-01
JP2766319B2 (ja) 1998-06-18
NZ229789A (en) 1991-04-26
US5037827A (en) 1991-08-06
HU9202211D0 (en) 1992-12-28
ATE120734T1 (de) 1995-04-15
JPH02131467A (ja) 1990-05-21
DD297814A5 (de) 1992-01-23
FI97883B (fi) 1996-11-29
DK329189D0 (da) 1989-07-03
PH26045A (en) 1992-01-29
EP0353474A3 (en) 1991-03-27
FI893099A0 (fi) 1989-06-26
AU3721389A (en) 1990-01-04
RU2040521C1 (ru) 1995-07-25
KR900001654A (ko) 1990-02-27
CA1334753C (en) 1995-03-14
HUT62855A (en) 1993-06-28
HUT52478A (en) 1990-07-28
DK329189A (da) 1990-01-05
NO177495B (no) 1995-06-19

Similar Documents

Publication Publication Date Title
NO159017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,3,4-tetrahydroisokinolin-3-karboksylsyre-derivater.
NO912410D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklen-derivater.
NO890723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-alkenyl-1-azabicyklo(3.2.0)hept2-en-2-karboksylsyrederivater.
FR2630328B1 (fr) Derive de l'histamine, sa preparation et son application en therapeutique
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
NO892743L (no) Fremgangsmaate for fremstilling av farmakologisk aktive glycerol-derivater.
NO881835D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser.
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
ES2068216T3 (es) Compuestos de tienotriazolodiazepina y usos farmaceuticos de los mismos.
DK707988D0 (da) Fremgangsmaade til at haemme virus
NO169648C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater
ATE122562T1 (de) Derivate von penciclovir zur behandlung von hepatitis-b-infektionen.
NO172541C (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater
NO171639C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolpyrazolderivater
NO167982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive penemderivater.
NO894325L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
ES2042727T3 (es) Acidos 1,3,4,9-tetrahidropirano(3,4-b)indol-1-acetico.
ATE95697T1 (de) Uricosuretische zusammensetzung.
DE69102389D1 (de) Verwendung eines benzo[b]thiophen-2-carboximidamid-Derivates gegen Herzinsuffizienz.
DE3889532D1 (de) Dihydropyridin-Verbindung zur Verbesserung der Adernausdehnung und Hemmung der Herzhypertrophie.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.